As both MMP-2 and EMMPRIN impact extracellular remodeling, this suggests that in vitro models for studying chemotherapy response in ovarian cancer may need to incorporate the stromal cells and extracellular matrix to better capture how tumor cells will respond. The gene discussed is MMP2; the disease is ovarian carcinoma.